Co-Diagnostics Expands Mosquito Surveillance Network Amid Florida Dengue Surge — Co-Diagnostics, Inc. (Co-Dx)

Event summary

Co-Diagnostics completed two new Vector Smart® lab installations in Florida, with a third in Indiana underway.
Florida reported 73 locally acquired dengue cases and 14 dengue-positive mosquito pools this season.
Vector Smart network now spans 21 U.S. states, including 7 mosquito abatement districts in Florida.
Platform designed for multi-pathogen surveillance, supporting recurring assay demand as installed base grows.

The big picture

Co-Diagnostics' expansion comes as vector-borne diseases like dengue emerge in new regions, increasing demand for decentralized molecular surveillance. The company positions Vector Smart as a scalable, multi-test platform that could become a critical component of public health infrastructure. Success will depend on maintaining momentum in installations and securing recurring assay demand.

What we're watching

Network Expansion: How quickly Co-Diagnostics can scale its Vector Smart installations across additional U.S. states and internationally.
Recurring Revenue: Whether the growing installed base will translate into sustained demand for consumable assays.
Regulatory Validation: The pace at which third-party validations will accelerate platform adoption in public health programs.